Pub Date : 2025-12-27eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf224
Nabeeha N Akram, Shaymaa K Abdulqader, Wassan N Mohammed, Qays A Hassan
Varicella (chickenpox) caused by varicella zoster virus is usually diagnosed clinically based on the typical presentation of fever and vesicular rash in immunocompetent children. However, atypical sites of the rash or non-cutaneous suppurative complications can cause a diagnostic dilemma. We report a tubo-ovarian abscess as an initial presentation of chickenpox in a 12-year-old female, a novel and unrecognized presentation of varicella in childhood. Unlike previously reported cases with varicella associated abscess that treated by intravenous antibiotics and surgical drainage, the current patient did not receive any medical or surgical therapy and spontaneous resolution of the abscess radiologically confirmed on serial follow up with imaging.
{"title":"Tubo-ovarian abscess as an initial presentation of varicella in 12 years old child; a case report.","authors":"Nabeeha N Akram, Shaymaa K Abdulqader, Wassan N Mohammed, Qays A Hassan","doi":"10.1093/omcr/omaf224","DOIUrl":"10.1093/omcr/omaf224","url":null,"abstract":"<p><p>Varicella (chickenpox) caused by varicella zoster virus is usually diagnosed clinically based on the typical presentation of fever and vesicular rash in immunocompetent children. However, atypical sites of the rash or non-cutaneous suppurative complications can cause a diagnostic dilemma. We report a tubo-ovarian abscess as an initial presentation of chickenpox in a 12-year-old female, a novel and unrecognized presentation of varicella in childhood. Unlike previously reported cases with varicella associated abscess that treated by intravenous antibiotics and surgical drainage, the current patient did not receive any medical or surgical therapy and spontaneous resolution of the abscess radiologically confirmed on serial follow up with imaging.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf224"},"PeriodicalIF":0.4,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12743295/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML); it has a high response rate and long-term survival with differentiation therapy and chemotherapy. However, only one previous case of APL with double minute chromosomes (DMs, a poor prognostic factor for AML) has been reported. We report the case of a patient with APL and DMs. A 44-year-old woman was treated with all-trans retinoic acid (ATRA) and chemotherapy and achieved molecular complete remission (mCR). However, the condition relapsed after 15 months. She was treated with arsenic trioxide and autologous transplantation and experienced mCR. Her peripheral blood was positive for minimal residual disease (MRD) 2 months after autologous transplantation. She became MRD-negative with ATRA and has maintained the negative status for 15 months. This is the first report to suggest that patients with APL and DMs may be a high-risk group for relapse and benefit from maintaining with ATRA.
{"title":"Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk.","authors":"Yohei Sasaki, Shotaro Shimada, Natsuki Kawamata, Hidenori Hayashi, Kazuki Nagao, Kai Kuroiwa, Hinako Narita, Reiko Okamura, Megumi Watanuki, Nana Arai, Kouji Yanagisawa, Norimichi Hattori","doi":"10.1093/omcr/omaf259","DOIUrl":"10.1093/omcr/omaf259","url":null,"abstract":"<p><p>Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML); it has a high response rate and long-term survival with differentiation therapy and chemotherapy. However, only one previous case of APL with double minute chromosomes (DMs, a poor prognostic factor for AML) has been reported. We report the case of a patient with APL and DMs. A 44-year-old woman was treated with all-trans retinoic acid (ATRA) and chemotherapy and achieved molecular complete remission (mCR). However, the condition relapsed after 15 months. She was treated with arsenic trioxide and autologous transplantation and experienced mCR. Her peripheral blood was positive for minimal residual disease (MRD) 2 months after autologous transplantation. She became MRD-negative with ATRA and has maintained the negative status for 15 months. This is the first report to suggest that patients with APL and DMs may be a high-risk group for relapse and benefit from maintaining with ATRA.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf259"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf256
Natalie García Cam, Alexandra Banda Baltodano, Yaime Condori-Arias, Alvaro Taype-Rondán
Alveolar rhabdomyosarcoma (ARMS) is the most aggressive subtype of rhabdomyosarcoma. Prognosis is closely linked to anatomical location, with parameningeal involvement and distant metastasis being associated with poorer outcomes. Diagnosis is challenging and requires immunohistochemistry, RT-PCR, and FISH. We report the case of a 17-year-old Peruvian male diagnosed with ARMS who presented with multiple adverse prognostic features, including parameningeal-paranasal disease, orbital invasion, distant metastasis, and PAX3-FOXO1 fusion. The clinical trajectory rapidly progressed and the patient succumbed. This case highlights not only the biological aggressiveness of ARMS, but also the systemic delays in diagnosis that may occur in resource-limited settings. Its educational value lies in raising awareness about diagnostic inequity in pediatric oncology and emphasizing the need for early suspicion and timely referral in atypical clinical presentations.
{"title":"Alveolar rhabdomyosarcoma of the paranasal sinuses with delayed diagnosis in a resource-constrained clinical setting: a case report.","authors":"Natalie García Cam, Alexandra Banda Baltodano, Yaime Condori-Arias, Alvaro Taype-Rondán","doi":"10.1093/omcr/omaf256","DOIUrl":"10.1093/omcr/omaf256","url":null,"abstract":"<p><p>Alveolar rhabdomyosarcoma (ARMS) is the most aggressive subtype of rhabdomyosarcoma. Prognosis is closely linked to anatomical location, with parameningeal involvement and distant metastasis being associated with poorer outcomes. Diagnosis is challenging and requires immunohistochemistry, RT-PCR, and FISH. We report the case of a 17-year-old Peruvian male diagnosed with ARMS who presented with multiple adverse prognostic features, including parameningeal-paranasal disease, orbital invasion, distant metastasis, and PAX3-FOXO1 fusion. The clinical trajectory rapidly progressed and the patient succumbed. This case highlights not only the biological aggressiveness of ARMS, but also the systemic delays in diagnosis that may occur in resource-limited settings. Its educational value lies in raising awareness about diagnostic inequity in pediatric oncology and emphasizing the need for early suspicion and timely referral in atypical clinical presentations.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf256"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf262
Hamdah Hanifa, Yumna Al-Badareen, Malak Mbarak Al-Refaai, Nafeaa M Ganama, Mohammad Sameeh Alabrash, Basil Alsaleh
Bartter Syndrome (BS) is a genetic disorder affecting the renal tubules, leading to elevated levels of renin, angiotensin, and aldosterone, along with metabolic alkalosis, while maintaining normal blood pressure. It is also associated with laboratory abnormalities such as hypocalcemia, hypokalemia, hypomagnesemia, and hyponatremia, which may result in neurological complications including seizures and loss of consciousness. These findings necessitate consideration of important differential diagnoses such as Gitelman syndrome and cystic fibrosis, underscoring the importance of confirming the diagnosis of this serious condition, giving it appropriate attention, and initiating early treatment to prevent advanced complications. We report the case of a 36-year-old Jordanian male with a medical history of Bartter Syndrome and chronic kidney disease, who presented to the emergency department in a coma with generalized seizures due to severe electrolyte imbalances. His condition was further complicated by a genetic predisposition and a family history of Bartter Syndrome, with genetic testing confirming mutations in the CLCNKB gene. This rare case of Bartter Syndrome type III, in which the patient progressed to the stage of hemodialysis, illustrates the complexities of diagnosis and management, and emphasizes the importance of continuous care and regular follow-up.
{"title":"Complexities of Bartter Syndrome Type III: A Case Study in Jordan.","authors":"Hamdah Hanifa, Yumna Al-Badareen, Malak Mbarak Al-Refaai, Nafeaa M Ganama, Mohammad Sameeh Alabrash, Basil Alsaleh","doi":"10.1093/omcr/omaf262","DOIUrl":"10.1093/omcr/omaf262","url":null,"abstract":"<p><p>Bartter Syndrome (BS) is a genetic disorder affecting the renal tubules, leading to elevated levels of renin, angiotensin, and aldosterone, along with metabolic alkalosis, while maintaining normal blood pressure. It is also associated with laboratory abnormalities such as hypocalcemia, hypokalemia, hypomagnesemia, and hyponatremia, which may result in neurological complications including seizures and loss of consciousness. These findings necessitate consideration of important differential diagnoses such as Gitelman syndrome and cystic fibrosis, underscoring the importance of confirming the diagnosis of this serious condition, giving it appropriate attention, and initiating early treatment to prevent advanced complications. We report the case of a 36-year-old Jordanian male with a medical history of Bartter Syndrome and chronic kidney disease, who presented to the emergency department in a coma with generalized seizures due to severe electrolyte imbalances. His condition was further complicated by a genetic predisposition and a family history of Bartter Syndrome, with genetic testing confirming mutations in the CLCNKB gene. This rare case of Bartter Syndrome type III, in which the patient progressed to the stage of hemodialysis, illustrates the complexities of diagnosis and management, and emphasizes the importance of continuous care and regular follow-up.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf262"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf255
Subhash Chandra Tard, Ayushi Shrivastav, Gajanand S Tanwar, Mukesh Beniwal
Multisystem Langerhans cell histiocytosis (MS-LCH) is exceedingly rare in very young children and can present with predominant lung involvement. We report a 2-year-old boy who presented with prolonged fever, cough, and acute respiratory distress. Chest imaging revealed recurrent bilateral pneumothoraces requiring multiple chest drains; high-resolution computed tomography showed diffuse bilateral thin-walled lung cysts. Thoracoscopic lung biopsy with immunohistochemistry (CD1a+, CD45+, S100+) confirmed Langerhans cell histiocytosis. Given the strong association between pediatric pulmonary LCH and multisystem disease, a whole-body FDG-PET/CT was performed, revealing hepatic and splenic involvement and confirming a diagnosis of MS-LCH. Systemic chemotherapy with vinblastine and corticosteroids led to clinical improvement. We also review nine similar pediatric cases reported in the literature, highlighting the importance of recognizing pulmonary findings as a gateway to diagnosing underlying multisystem LCH.
{"title":"Multisystem Langerhans cell Histiocytosis presenting with spontaneous pneumothorax in a toddler: case report and literature review.","authors":"Subhash Chandra Tard, Ayushi Shrivastav, Gajanand S Tanwar, Mukesh Beniwal","doi":"10.1093/omcr/omaf255","DOIUrl":"10.1093/omcr/omaf255","url":null,"abstract":"<p><p>Multisystem Langerhans cell histiocytosis (MS-LCH) is exceedingly rare in very young children and can present with predominant lung involvement. We report a 2-year-old boy who presented with prolonged fever, cough, and acute respiratory distress. Chest imaging revealed recurrent bilateral pneumothoraces requiring multiple chest drains; high-resolution computed tomography showed diffuse bilateral thin-walled lung cysts. Thoracoscopic lung biopsy with immunohistochemistry (CD1a+, CD45+, S100+) confirmed Langerhans cell histiocytosis. Given the strong association between pediatric pulmonary LCH and multisystem disease, a whole-body FDG-PET/CT was performed, revealing hepatic and splenic involvement and confirming a diagnosis of MS-LCH. Systemic chemotherapy with vinblastine and corticosteroids led to clinical improvement. We also review nine similar pediatric cases reported in the literature, highlighting the importance of recognizing pulmonary findings as a gateway to diagnosing underlying multisystem LCH.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf255"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf260
Ibrahim AboGhayyada, Mohammad Zeidan, Taha Z Makhlouf, Amir AbuGhiyatha, Mosab Ghnimat, Mohammad Najajreh
Background: Plasminogen deficiency is an ultra-rare autosomal recessive disorder characterized by impaired fibrinolysis and the formation of fibrin-rich pseudomembranes. Ligneous conjunctivitis is the most common manifestation, whereas central nervous system involvement, such as hydrocephalus, is rare. Early recognition is essential to prevent irreversible complications.
Case presentation: We report a 3-year-old girl with progressive macrocephaly, antenatal hydrocephalus, and persistent pseudomembranous conjunctivitis. Imaging showed fused lateral ventricles and agenesis of the corpus callosum, consistent with obstructive hydrocephalus requiring multiple ventriculoperitoneal shunt revisions. Genetic testing confirmed type I plasminogen deficiency with a homozygous PLG mutation. Recombinant plasminogen was unavailable, and she was managed with fresh frozen plasma (FFP) infusions plus ophthalmic and anticonvulsant therapy.
Outcome: Regular FFP stabilized her ocular and neurological condition, though recurrent shunt complications necessitated repeated hospitalizations.
Conclusion: This case illustrates the diagnostic challenges of type I plasminogen deficiency and highlights FFP as a practical therapeutic option in resource-limited settings.
{"title":"Fresh frozen plasma therapy in type I plasminogen deficiency: a case of ligneous conjunctivitis with hydrocephalus.","authors":"Ibrahim AboGhayyada, Mohammad Zeidan, Taha Z Makhlouf, Amir AbuGhiyatha, Mosab Ghnimat, Mohammad Najajreh","doi":"10.1093/omcr/omaf260","DOIUrl":"10.1093/omcr/omaf260","url":null,"abstract":"<p><strong>Background: </strong>Plasminogen deficiency is an ultra-rare autosomal recessive disorder characterized by impaired fibrinolysis and the formation of fibrin-rich pseudomembranes. Ligneous conjunctivitis is the most common manifestation, whereas central nervous system involvement, such as hydrocephalus, is rare. Early recognition is essential to prevent irreversible complications.</p><p><strong>Case presentation: </strong>We report a 3-year-old girl with progressive macrocephaly, antenatal hydrocephalus, and persistent pseudomembranous conjunctivitis. Imaging showed fused lateral ventricles and agenesis of the corpus callosum, consistent with obstructive hydrocephalus requiring multiple ventriculoperitoneal shunt revisions. Genetic testing confirmed type I plasminogen deficiency with a homozygous PLG mutation. Recombinant plasminogen was unavailable, and she was managed with fresh frozen plasma (FFP) infusions plus ophthalmic and anticonvulsant therapy.</p><p><strong>Outcome: </strong>Regular FFP stabilized her ocular and neurological condition, though recurrent shunt complications necessitated repeated hospitalizations.</p><p><strong>Conclusion: </strong>This case illustrates the diagnostic challenges of type I plasminogen deficiency and highlights FFP as a practical therapeutic option in resource-limited settings.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf260"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Garré's chronic sclerosing osteomyelitis is a rare, nonsuppurative form of chronic osteomyelitis, typically seen in children and adolescents, and characterized by periosteal bone proliferation. This case report presents an unusual manifestation in a 20-year-old male with recurrent swelling of the left cheek and trismus, in whom imaging and clinical evolution supported the diagnosis. The management approach and follow-up imaging are discussed, and the case is contextualized within the existing literature.
{"title":"Garré's Chronic Sclerosing Osteomyelitis: An Overview of Clinical and Radiologic Features.","authors":"Mohamed Fadil, Ayman Farouki, Rachida Saouab, Hassan En-Nouali, Jamal El Fenni, Zakariya Toufga","doi":"10.1093/omcr/omaf276","DOIUrl":"10.1093/omcr/omaf276","url":null,"abstract":"<p><p>Garré's chronic sclerosing osteomyelitis is a rare, nonsuppurative form of chronic osteomyelitis, typically seen in children and adolescents, and characterized by periosteal bone proliferation. This case report presents an unusual manifestation in a 20-year-old male with recurrent swelling of the left cheek and trismus, in whom imaging and clinical evolution supported the diagnosis. The management approach and follow-up imaging are discussed, and the case is contextualized within the existing literature.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf276"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf266
Jiaan-Der Wang, Cheng-Ta Chou
{"title":"Claw hands in acute intermittent porphyria.","authors":"Jiaan-Der Wang, Cheng-Ta Chou","doi":"10.1093/omcr/omaf266","DOIUrl":"10.1093/omcr/omaf266","url":null,"abstract":"","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf266"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741424/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sorafenib is a multi-target kinase inhibitor used to treat advanced cancers, such as hepatocellular carcinoma. It has been associated with various cutaneous adverse events and here we report a new potential skin reaction-Trichodysplasia Spinulosa (TS)-and explore its differential diagnosis with Follicular Hyperkeratosis (FH), both possibly induced by Sorafenib. we highlight the role of sorafenib in disrupting skin keratinization process and propose a mechanism for this reaction, especially in immunosuppressed individuals.
{"title":"Sorafenib-associated Trichodysplasia Spinulosa versus Follicular Hyperkeratosis: a case report.","authors":"Reem Hasan, Nemat Alsaghir, Kinda Alshawa, Sajeda Alnabelsi, Hanaa Almsokar","doi":"10.1093/omcr/omaf273","DOIUrl":"10.1093/omcr/omaf273","url":null,"abstract":"<p><p>Sorafenib is a multi-target kinase inhibitor used to treat advanced cancers, such as hepatocellular carcinoma. It has been associated with various cutaneous adverse events and here we report a new potential skin reaction-Trichodysplasia Spinulosa (TS)-and explore its differential diagnosis with Follicular Hyperkeratosis (FH), both possibly induced by Sorafenib. we highlight the role of sorafenib in disrupting skin keratinization process and propose a mechanism for this reaction, especially in immunosuppressed individuals.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf273"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-26eCollection Date: 2025-12-01DOI: 10.1093/omcr/omaf271
Mohammed AbuBaha, Bara AbuBaha, Hossam Salameh, Asem Afana, Ibrahim Abseh, Hatem Taha
Introduction: Low-molecular-weight heparins (LMWHs) are widely used during pregnancy and postpartum to prevent thrombosis and are generally safe. Rarely, they can trigger delayed hypersensitivity reactions causing skin necrosis and infection. Recognizing this complication is important for timely care.
Case presentation: A 40-year-old woman developed painful necrotic patches at enoxaparin injection sites on her abdomen and arm one week after cesarean delivery. The lesions were red, tender, and associated with elevated inflammatory markers, while platelet counts were normal, excluding heparin-induced thrombocytopenia. She was diagnosed with LMWH-induced delayed hypersensitivity complicated by cellulitis. Enoxaparin was stopped, and she recovered with apixaban, intravenous antibiotics, wound care, and partial debridement.
Discussion: These reactions usually appear 5-14 days after starting LMWH and can mimic infection or thrombosis. They reflect T-cell-mediated vascular injury and require clinical attention.
Conclusion: LMWH-induced skin necrosis is rare but serious. Early recognition and switching to alternative anticoagulation are essential for favorable outcomes.
{"title":"When prophylaxis turns pathologic: a case of LMWH-induced necrosis with secondary cellulitis.","authors":"Mohammed AbuBaha, Bara AbuBaha, Hossam Salameh, Asem Afana, Ibrahim Abseh, Hatem Taha","doi":"10.1093/omcr/omaf271","DOIUrl":"10.1093/omcr/omaf271","url":null,"abstract":"<p><strong>Introduction: </strong>Low-molecular-weight heparins (LMWHs) are widely used during pregnancy and postpartum to prevent thrombosis and are generally safe. Rarely, they can trigger delayed hypersensitivity reactions causing skin necrosis and infection. Recognizing this complication is important for timely care.</p><p><strong>Case presentation: </strong>A 40-year-old woman developed painful necrotic patches at enoxaparin injection sites on her abdomen and arm one week after cesarean delivery. The lesions were red, tender, and associated with elevated inflammatory markers, while platelet counts were normal, excluding heparin-induced thrombocytopenia. She was diagnosed with LMWH-induced delayed hypersensitivity complicated by cellulitis. Enoxaparin was stopped, and she recovered with apixaban, intravenous antibiotics, wound care, and partial debridement.</p><p><strong>Discussion: </strong>These reactions usually appear 5-14 days after starting LMWH and can mimic infection or thrombosis. They reflect T-cell-mediated vascular injury and require clinical attention.</p><p><strong>Conclusion: </strong>LMWH-induced skin necrosis is rare but serious. Early recognition and switching to alternative anticoagulation are essential for favorable outcomes.</p>","PeriodicalId":45318,"journal":{"name":"Oxford Medical Case Reports","volume":"2025 12","pages":"omaf271"},"PeriodicalIF":0.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12741445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}